Global Health

Dr. Samuel (SAS) Kargbo speaks on the Aspen Institute’s Spotlight Health Conference on the life-saving strategy and understanding he brokered in Sierra Leone during the Ebola crisis. 

Listen to the full audio of the panel here: https://soundcloud.com/aspenideastogo/undaunted-stories-from-the-frontlines-of-global-health

S.A.S. Kargbo — Stories From The Frontlines Of Global Health

Genepod

Genepod: July 2016 - The real father of Precision Medicine

Dexter Hadley of UCSF speaks to CHI on November, 29, 2016. Dr. Hadley will be speaking during the Bioinformatics track during the Molecular Medicine Triconference, February 19 - 24, in San Francisco, CA. 

Topics include developing a learning healthcare system to help make medicine more objective rather than subjective in terms of identifying melanoma and other symptoms, as well as creating an app to bring better personalized medicine to individuals.

For more information, please visit http://www.TriConference.com/Bioinformatics-Big-Data/

Molecular Med Tri-Con 2017 | Using Big Data to Create Better Precision Medicine

Hear an interview with Geisinger Health System's Jennifer Wagner, who discusses her recent publication in Genetics in Medicine which addresses how to get the most out of the Precision Medicine Initiative.

Genepod - December 2016 - Making Precision Medicine Work

Today we are delighted to bring you an interview with Matt Might, computer scientist and medical researcher extraordinaire and architect of President Obama's Precision Medicine Initiative.  As the Obama Administration winds down, we're talking with Matt about the goals and accomplishments of precision medicine (and related projects like the Cancer Moonshot) and what he foresees as the future marriage of data and medicine.  Many thanks to Matt, our friends over at Partially Derivative (hi, Jonathon!) and the White House for arranging this opportunity to chat.  Enjoy!

Data and the Future of Medicine : Interview with Precision Medicine Initiative researcher Matt Might

Dr. Jennifer Chadwick shares her journey from academia to industry, and the best advice that got her to where she is today.

PEGS Boston 2019 | Jennifer Chadwick’s Story of Building a Creative and Authentic Career in Science

Dr. Mark Stewart discusses the role of the tumor mutational burden (TMB) in cancer research and the need for harmonization throughout the process.

For more information, please visit https://www.triconference.com/Companion-Diagnostics

Molecular Med Tri-Con 2019 | Target the Tumor Mutational Burden and Pursue Harmonization

Harry Glorikian interviews Niven R. Narain about his approach on how to add more precision to the process of drug development and diagnostic development while engage more reproducibility. Niven also discusses how to use the biomarkers not only as a readout but as a vehicle and an agent to design clinical trials much differently.

For more information, please visit https://www.TriConference.com/Precision-Medicine

Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

Dr. Richard Levenson discusses the role of AI in digital pathology – what works, and what needs to be done for AI to reach its full potential.

For more information, please visit https://www.TriConference.com/Digital-Pathology

Molecular Med Tri-Con 2019 | Putting the AI in Wait

Dr. Konstantinos Mitsakakis explains the One Health approach, and how the pursuit benefits diverse avenues of diagnostic research.

For more information, please visit https://www.MolecularDXEurope.com/Point-of-Care-Dx

Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach

Samuel Levy of Bluestar Genomics speaks to CHI on March 13, 2019. Dr. Levy will be speaking during The Liquid Biopsy Summit, June 17-19, in San Francisco, CA.
 
Topics include cell-free diagnostics in precision medicine, transformation & growth in the liquid biopsy field, epigenomic assays for cancer detection, and opportunities ahead.

For more information, please visit https://www.LiquidBiopsySummit.com/Programs

the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics

Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health.

For more information, please visit https://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics

Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

Nancy Sajjadi, an independent bioassay quality consultant with over 30 years of experience in biopharmaceutical product development, discusses her history in the bioassay field and how her experience has fostered her passion for teaching biostatistics to non-statisticians with CHI.
 
Topics include: challenges in developing bioassays for cell & gene therapies, regulatory considerations and standards for bioassays, fostering collaboration between statisticians and bench scientists, and more

For more information, please visit https://www.ImmunogenicitySummit.com/Workshop

Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics

Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field.

For more information, please visit https://www.TriConference.com/Gene-Therapy

Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years. 

For more information, please visit https://www.TriConference.com/Precision-Medicine

Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine

Use Our Intel supports government and industry leaders by providing news, analysis, intelligence via email newsletters, digital reports, and online publications.

We are a leading source for coverage of trends and developments for industry and government at the federal, state, and local level. Our content reaches across sectors and departments.

Explore our media brands (Homeland Security Review, Global Security Wire, Global Health News Wire, Global Cyber Security Report , Water Security News Wire, Africa Security News Wire, Latin America Security Report , Homeland Security News Wire, Space & Planetary News Wire, Open Data News Wire) and our digital services- Calendar Tribe, PressPlay Stratcomm, and Data Intelligentsia

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.

Molecular Med Tri-Con 2017 | Using Big Data to Create Better Precision Medicine

CHI Podcasts

Related tracks